PrimeRFP SCOUT · Federal Contract Recompete Brief

75F40125F80062Biosimilar and interchangeable continuing — Webmd Health Corp

Webmd Health Corp holds $7.0M across 33 federal awards, concentrated at Department of Health and Human Services (HHS). This PIID sits alongside 2 related awards under parent GS02F0034W. The prior award was single-bid — competitive dynamics may favor a challenge. PoP ended Jun 30, 2026 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

Fda Office Of Acq Grant Svcs

Awarding office

Webmd Health Corp

Recipient

Jun 30, 2026

PoP end

$1.1M

Obligated

$6.8M

Potential

611430

NAICS

R425

PSC

1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Webmd Health Corp — $90

Contract facts

Federal

Contract number75F40125F80062

Also listed asGS02F0034W-75F40125F80062

AgencyFda Office Of Acq Grant Svcs

Awarding officeFda Office Of Acq Grant Svcs

Awarding agencyDepartment of Health and Human Services (HHS)

Funding agencyDepartment of Health and Human Services (HHS)

IncumbentWebmd Health Corp

CAGE4PTZ0

UEILJ8EVFE8SB55

NAICS611430

No full NAICS 611430 intel page yet. Browse NAICS intelligence

PSCR425

Parent IDIQ / IDVGS02F0034W

Place of performanceNEWARK NJ

Pricing typeFirm Fixed Price

Extent competedFull And Open Competition

PoP startApr 29, 2025

PoP end (current)Jun 30, 2026

PoP end (w/ options)May 1, 2030

Obligated$1.1M

Current value$1.1M

Potential value$6.8M

BIOSIMILAR AND INTERCHANGEABLE CONTINUING EDUCATION is a federal award for Fda Office Of Acq Grant Svcs held by Webmd Health Corp. Estimated value $6.8M ($1.1M obligated). Current period of performance ends Jun 30, 2026 (potential May 1, 2030). Last award drew 1 bidder. Place of performance: NEWARK NJ.

BIOSIMILAR AND INTERCHANGEABLE CONTINUING EDUCATION

Recompete timing

Public

● Past PoP end (52 days ago)

Current PoP ended Jun 30, 2026 (52 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Incumbent footprint

Public record

Webmd Health Corp — $7.0M obligated across 33 awards (firm-wide, all agencies).

Sole agency: Department of Health and Human Services (HHS)

Department of Health and Human Services (HHS)$6.8M · 100% of firm total

Open full company profile →

Related awards

Same parent · incumbent

75D30125F20649

TECHNICAL SERVICES - SPOLIGHT COURSES

$214K

Sep 25, 2027

75P00124F80197

ACCREDITED CONTINUING PROFESSIONAL EDUCATION SERVICES FOR HEALTHCARE PROVIDERS ON WOMEN'S …

$3.2M

Sep 29, 2027

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 75F40125F80062?

75F40125F80062 (Biosimilar and interchangeable continuing) is a Fda Office Of Acq Grant Svcs award with a potential value of $6.8M, currently held by Webmd Health Corp. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 75F40125F80062?

Fda Office Of Acq Grant Svcs awarded 75F40125F80062 to Webmd Health Corp (potential $6.8M).

Who is the incumbent on 75F40125F80062?

Webmd Health Corp is the incumbent with $7.0M across 33 related awards in SCOUT’s public footprint. The current period of performance ends Jun 30, 2026.

When does Webmd Health Corp’s 75F40125F80062 come up for recompete?

SCOUT tracks a period-of-performance end of Jun 30, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Jun 25, 2026 · refreshed monthlyLatest procurement action Jun 26, 2026